| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/12/2009 | US20090068288 Topical antiseptic veterinary solution |
| 03/12/2009 | US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt |
| 03/12/2009 | US20090068272 Mesoporous calcium silicate compositions and methods for synthesis of mesoporous calcium silicate for controlled release of bioactive agents |
| 03/12/2009 | US20090068259 Controlled Surface Gelling of Mucoadhesive Polymers on Oral Mucosa |
| 03/12/2009 | US20090068256 Encapsulation of Bioactive Complexes in Liposomes |
| 03/12/2009 | US20090068239 Refreshment towel and applied solution |
| 03/12/2009 | US20090068213 Immunogenic composition for early detection of dengue virus |
| 03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
| 03/12/2009 | US20090068185 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/12/2009 | US20090068174 Therapeutic alkaline protease compositions and use in facilitating the transport of agents across the gastrointestinal mucosal lining |
| 03/12/2009 | US20090068172 Compositions and methods comprising binding proteins for adalimumab |
| 03/12/2009 | US20090068166 Method and composition for protection against radiation |
| 03/12/2009 | US20090068165 Uniformly Conjugated Serine Hydrolases |
| 03/12/2009 | US20090068159 Insecticidal Compositions and Methods for Making Insect-Resistant Transgenic Plants |
| 03/12/2009 | US20090068148 Peptides of cav2.2 that inhibit pain |
| 03/12/2009 | US20090068139 LOOP PEPTIDE AND TGF alpha FOR STIMULATING STEM CELL PROLIFERATION AND MIGRATION |
| 03/12/2009 | CA2698665A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
| 03/12/2009 | CA2698377A1 Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis |
| 03/12/2009 | CA2697737A1 Method for promoting expression of p53, and p53 expression promoter for use in the method |
| 03/11/2009 | EP2034018A1 Genetically modified animal and use thereof |
| 03/11/2009 | EP2034017A1 Gene involved in immortalization of human cancer cell and use thereof |
| 03/11/2009 | EP2033972A1 Screening method for candidate drugs |
| 03/11/2009 | EP2033954A1 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor |
| 03/11/2009 | EP2033952A1 Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity |
| 03/11/2009 | EP2033951A2 2-Piperazine-pyridines useful for treating pain |
| 03/11/2009 | EP2033659A2 Inhibitors of complement activation |
| 03/11/2009 | EP2033651A1 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease |
| 03/11/2009 | EP2033648A2 Sustained release drug delivery system containing codrugs |
| 03/11/2009 | EP2033644A1 Spiroindene and spiroindane compounds |
| 03/11/2009 | EP2033643A1 Compressed preparation |
| 03/11/2009 | EP2033633A2 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure |
| 03/11/2009 | EP2033514A2 Carbon Monoxide Improves Outcomes in Cell and Organ Transplants and Suppresses Apoptosis |
| 03/11/2009 | EP1499622B1 Heterotricyclyl 6-alkylidene-penems as beta-lactamase inhibitors |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP1480984B9 Hexacyclic compounds |
| 03/11/2009 | EP1456182B1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i) |
| 03/11/2009 | EP1435899B1 A composition for promoting hair growth |
| 03/11/2009 | EP1358165B1 Imidazole derivatives |
| 03/11/2009 | EP1326586B1 New pharmaceutical compositions containing epinastine and pseudoephedrine |
| 03/11/2009 | EP1317445B1 Chemokine receptor binding heterocyclic compounds |
| 03/11/2009 | EP1302476B1 Reduced fk228 and use thereof |
| 03/11/2009 | EP1294384B1 Use of lanthanum compounds for the treatment of bone diseases |
| 03/11/2009 | EP1175399B1 Inhibitors of c-jun n-terminal kinases (jnk) |
| 03/11/2009 | EP1173567B1 Tribonectins |
| 03/11/2009 | EP1165564B1 Process for preparing inhibitors of nucleoside metabolism |
| 03/11/2009 | EP0988374B1 Hydrophilic composition containing protease produced by vibrio proteolyticus |
| 03/11/2009 | CN101384608A Method of producing extract derived from hypsizigus marmoreus |
| 03/11/2009 | CN101384266A Fixed-dose association of phytate and zinc |
| 03/11/2009 | CN101384257A Drug combinations |
| 03/11/2009 | CN101381725A Circular dumbbell decoy oligodeoxynucleotide (CDODN) containing transcription DNA binding sites |
| 03/11/2009 | CN101381401A Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 03/11/2009 | CN101381379A Kinase inhibitor phosphonate conjugates |
| 03/11/2009 | CN101381366A Benzimidazole derivative and its use as a ii receptor antagonist |
| 03/11/2009 | CN101380464A Method for treating a movement disorder |
| 03/11/2009 | CN101380452A Preparation method of no-alcohol type Shexiang Qushu liquid oral preparation |
| 03/11/2009 | CN101380451A Preparation method of no-alcohol type Liusheng Qushu liquid oral preparation |
| 03/11/2009 | CN101380432A Oral liquid for clearing warm and counteracting a toxin |
| 03/11/2009 | CN101380430A Oral liquid for nourishing yin and suppressing the excessive yang |
| 03/11/2009 | CN101380429A Oral liquid capable of calming the liver to stop the wind |
| 03/11/2009 | CN101380426A Traditional Chinese medicine composition for preventing and treating birds inappetence and growth retardation |
| 03/11/2009 | CN101380382A Traditional Chinese medicine extract with antioxidation activity and preparation method and use thereof |
| 03/11/2009 | CN101380322A A new use for deferiprone |
| 03/11/2009 | CN101380320A The use of cholinesterase inhibitors in the treatment of xerostomia |
| 03/11/2009 | CN101380319A Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 03/11/2009 | CN100467603C DNA sequences coding for the human proteins TX and TY related to the interleukin-IBeta converting enzyme |
| 03/11/2009 | CN100467600C Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/11/2009 | CN100467583C Beta glucan-containing fat and oil compositions and novel microorganism capable of producing beta-glucan |
| 03/11/2009 | CN100467469C A2b adenosine receptor antagonists |
| 03/11/2009 | CN100467461C N-oxyde of N-phenyl-2-pyrimidine-amine derivatives |
| 03/11/2009 | CN100467449C Cyclic aminophenyl sulfamate derivative |
| 03/11/2009 | CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 03/11/2009 | CN100467440C Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
| 03/11/2009 | CN100467060C Intratumorally administered lactoferrin in the treatment of malignant neoplasms diseases |
| 03/11/2009 | CN100467059C Use of lactoferrin in the treatment of malignant neoplasms diseases |
| 03/11/2009 | CN100467058C Pharmaceutical and cosmetic compositions comprising PLGF-1 |
| 03/11/2009 | CN100467030C Trachyostracous mussel extract and its preparation and use |
| 03/11/2009 | CN100467023C Use of N-(3-methoxy-5-methyl pyrazine-2-group)-2-(4-[1,3,4-oxadiazole-2-group]phenyl) pyridine-3-sulfanilamide as anticarcinogen |
| 03/10/2009 | US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents |
| 03/10/2009 | US7501485 Wound heraling agents; polypeptide |
| 03/10/2009 | US7501441 for treating uterine fibroid disease; [2-(4-hydroxyphenyl)-6-hydroxynaphthalen-1-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]methane; therapy for post manupausal women |
| 03/10/2009 | US7501437 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 03/10/2009 | US7501431 Physiologically active substances PF1270A, B and C substances |
| 03/10/2009 | US7501425 e.g. 1-Methyl-7-[4-(pyrazol-1-yl)phenylamino]pyrimido[4,5-d]pyrimidin-2(1H)-one; anticarcinogenic agents; restenosis, angiogenesis and atherosclerosis |
| 03/10/2009 | US7501418 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity |
| 03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/10/2009 | US7501412 e.g. 4-(1-(2-hydroxyethyl)piperidin-4-yl)-2H-isoquinolin-1-one; poly(ADP-ribose)polymerase inhibitor; nicotinamide nucleotide (NAD) substrate; acute cerebral infarction |
| 03/10/2009 | US7501409 A tablet has an acid, with reduced solubility in the neutral and alkaline regions, is used for treating sexual disorders erectile dysfunction |
| 03/10/2009 | US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens |
| 03/10/2009 | US7501403 Bile acid or bile salt fatty acid conjugates |
| 03/10/2009 | US7501265 Method for producing and cleaving a fusion proteins with an n-terminal chymosin pro-peptide |
| 03/10/2009 | US7501263 Nucleic acids encoding mammalian T-type calcium channels |
| 03/10/2009 | CA2468649C Adenosine a2a receptor antagonists |
| 03/10/2009 | CA2394602C New modulators of dopamine neurotransmission |
| 03/10/2009 | CA2289851C Compounds and methods for the inhibition of the expression of vcam-1 |
| 03/10/2009 | CA2285263C Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 03/05/2009 | WO2009028655A1 Heterocyclic compound and use thereof |
| 03/05/2009 | WO2009028631A1 Agent for promoting corneal endothelial cell adhesion |
| 03/05/2009 | WO2009028629A1 Heterocyclic compound and use thereof |
| 03/05/2009 | WO2009028605A1 Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent |
| 03/05/2009 | WO2009028588A1 Polycyclic compound |